DetectaChem's experience with bomb and drug detection technology enabled them to quickly pivot during the pandemic. The company's smartphone-based COVID-19 test is currently advancing through the NIH RADx initiative.
FDA will apply enforcement discretion to allow at-home administration of CapsoVision's CapsoCam Plus small bowel capsule endoscope during the COVID-19 pandemic for patients who are eligible for at-home administration.
Google first announced it would acquire Fitbit for $2.1 billion in November of 2019. EU antitrust regulators offered concerns over the deal because of the amount of data Google would have access to.
The Palo Alto, CA-based company won breakthrough device designation from FDA in 2018.
Bexson Biomedical and Stevanato Group will team up for a programmable wearable that provides subcutaneous ketamine delivery.
Inherent Biosciences has been awarded funds to develop a dataset of COVID-19 infection biomarkers against which AI would compare patient blood samples.
MD+DI has compiled a list of 10 cleared or approved wearable medical devices by FDA that have caused a paradigm shift in healthcare.
Pressed for time? Here's the medtech news you need most, in one minute or less.
Here’s what was new in the world of medical device suppliers during the week of September 13.